KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Goodwill & Intangibles: 2017-2024

Historic Goodwill & Intangibles for BeOne Medicines (ONC) over the last 8 years, with Dec 2024 value amounting to $51.1 million.

  • BeOne Medicines' Goodwill & Intangibles rose 17.88% to $63.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.6 million, marking a year-over-year increase of 17.88%. This contributed to the annual value of $51.1 million for FY2024, which is 10.58% down from last year.
  • As of FY2024, BeOne Medicines' Goodwill & Intangibles stood at $51.1 million, which was down 10.58% from $57.1 million recorded in FY2023.
  • In the past 5 years, BeOne Medicines' Goodwill & Intangibles registered a high of $57.1 million during FY2023, and its lowest value of $5.0 million during FY2020.
  • For the 3-year period, BeOne Medicines' Goodwill & Intangibles averaged around $49.6 million, with its median value being $51.1 million (2024).
  • As far as peak fluctuations go, BeOne Medicines' Goodwill & Intangibles fell by 14.47% in 2020, and later spiked by 833.58% in 2021.
  • Yearly analysis of 5 years shows BeOne Medicines' Goodwill & Intangibles stood at $5.0 million in 2020, then skyrocketed by 833.58% to $46.7 million in 2021, then declined by 12.99% to $40.6 million in 2022, then spiked by 40.68% to $57.1 million in 2023, then dropped by 10.58% to $51.1 million in 2024.